It's a sacred cow topic. But the solution is to convert them to competitive markets. We want to see more biosimilars. We want to see more competition, more choices. When the first biosimilar came on the market seven years after Humira's patent expired, prices really didn't go down. Call it an implied collusion of prices, but it takes typically until two or three biosimilars come to market to see the prices really drop. (14:33–14:43)
CLAIM
Asserts that prices did not decrease when the first biosimilar entered the market seven years after Humira's patent expired.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.